Related Experiment Video
Updated: Apr 6, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.4K
Medical writing on an accelerated path in India
1Department of Medical Writing, TATA Consultancy Services, Mumbai, Maharashtra, India.
Perspectives in Clinical Research
|August 1, 2015
Summary
India
Area of Science:
- Medical writing
- Pharmaceutical industry
- Drug development
Background:
- The medical writing industry is experiencing significant growth in India.
- This expansion is fueled by the need for high-quality documentation for drug approvals.
- Emerging economies like India offer the necessary expertise for medical writing services.
Purpose of the Study:
- To review the business landscape of medical writing in India.
- To identify opportunities and challenges in outsourcing medical writing to India.
- To analyze essential competencies for medical writers and relevant professional associations.
Main Methods:
- Literature review of the medical writing industry in India.
- Analysis of market trends and outsourcing dynamics.
- Competency assessment for medical writers.
Main Results:
- India presents a growing market for medical writing services.
- Key opportunities include cost-effectiveness and skilled workforce.
- Challenges involve quality control and intellectual property protection.
- Essential competencies include scientific knowledge, writing skills, and regulatory understanding.
Conclusions:
- India is a prime destination for outsourcing medical writing due to its growing capabilities and cost advantages.
- Addressing challenges is crucial for sustained growth and maintaining quality standards in the Indian medical writing sector.
- Professional development and adherence to industry standards are vital for medical writers.
Related Concept Videos
Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Preclinical Development: Overview
6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Bioequivalence studies: Biowaivers
398
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
398
Drug Administration and Therapy Phases: Overview
1.7K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.7K
Methods of Documentation VI: Case Management Model
1.0K
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
1.0K

